These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 19840244

  • 1. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY, He XD, Qu Q, Cai L, Liu W, Zhou L, Zhang SM.
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, Hassan MM.
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [Abstract] [Full Text] [Related]

  • 3. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas.
    Qu Z, Cui N, Qin M, Wu X.
    Asia Pac J Clin Oncol; 2012 Mar; 8(1):83-7. PubMed ID: 22369448
    [Abstract] [Full Text] [Related]

  • 4. [Case-control study of risk factors in cholangiocarcinoma].
    Tao LY, He XD, Cai L, Liu W, Ji WJ, Zhao L, Zhang SM.
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.
    Zhou H, Wang H, Zhou D, Wang H, Wang Q, Zou S, Tu Q, Wu M, Hu H.
    Eur J Cancer; 2010 Apr; 46(6):1056-61. PubMed ID: 20202823
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.
    Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, Kwon S, Lee SK, Seo DW, Kim MH, Suh DJ.
    Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716
    [Abstract] [Full Text] [Related]

  • 7. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, Fiel MI, Schwartz M, Thung SN.
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [Abstract] [Full Text] [Related]

  • 8. The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China.
    Wu Q, He XD, Yu L, Liu W, Tao LY.
    Asian Pac J Cancer Prev; 2012 Feb; 13(5):1963-9. PubMed ID: 22901155
    [Abstract] [Full Text] [Related]

  • 9. [Risk factors of intrahepatic cholangiocarcinoma: a case-control study].
    Zhou HB, Xu QR, Wang H, Zhou DX, Wang H, Wang Q, Zhou SS, Tu QQ, Sun ZQ, Ai L, Wu MC, Hu HP.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):935-9. PubMed ID: 20038337
    [Abstract] [Full Text] [Related]

  • 10. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.
    Jing W, Jin G, Zhou X, Zhou Y, Zhang Y, Shao C, Liu R, Hu X.
    Eur J Cancer Prev; 2012 Jan; 21(1):24-31. PubMed ID: 21857525
    [Abstract] [Full Text] [Related]

  • 11. The epidemiology of cholangiocarcinoma.
    Shaib Y, El-Serag HB.
    Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
    Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, El Ghormli L, Olsen JH, McGlynn KA.
    Int J Cancer; 2007 Feb 01; 120(3):638-41. PubMed ID: 17109384
    [Abstract] [Full Text] [Related]

  • 13. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
    Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M.
    Am J Surg Pathol; 2007 Jul 01; 31(7):1059-67. PubMed ID: 17592273
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.
    Lee BS, Park EC, Park SW, Nam CM, Roh J.
    World J Gastroenterol; 2015 Jan 14; 21(2):502-10. PubMed ID: 25593465
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
    Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA.
    Clin Gastroenterol Hepatol; 2007 Oct 14; 5(10):1221-8. PubMed ID: 17689296
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus and intrahepatic cholangiocarcinoma.
    Gatselis NK, Tepetes K, Loukopoulos A, Vasiou K, Zafiriou A, Gioti C, Dalekos GN.
    Cancer Invest; 2007 Feb 14; 25(1):55-8. PubMed ID: 17364558
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
    Torbenson M, Yeh MM, Abraham SC.
    Am J Surg Pathol; 2007 Sep 14; 31(9):1410-3. PubMed ID: 17721197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.